The STI’s 5 largest weights – DBS, OCBC, UOB, SingTel and Jardine Matheson make up 56% of the STI weights, and have averaged 9% quarter-to-date total returns, bringing their average year-to-date total return to 10%. For the quarter-to-date, the 5 stocks have seen combined net fund inflows S$1.25 billion.
Singapore’s 5 most traded consumer cyclical stocks year-to-date include Genting Singapore, Jardine Cycle & Carriage, NIO Inc, The Hour Glass and mm2 Asia. Singapore’s 5 most traded consumer non-cyclical stocks include Wilmar International, Thai Beverage, Golden Agri-Resources, First Resources and Sheng Siong.
The 10 Singapore-listed stocks, that have averaged more than S$1mil in daily turnover in the 2022 year-to-date, and saw the most percentage increases in daily trading turnover as compared to the full 2021 year, include as many as 3 Energy plays – Golden Energy & Resources, Geo Energy Resources and RH Petrogas.
The iEdge SG Advanced Manufacturing Index have has declined 4% in the 3Q22 to 7 Sep, while booking S$10 million of net institutional inflows. NIO (SGX:NIO), Venture Corporation (SGX:V03), Wilmar International (SGX:F34), ST Engineering (SGX:S63) and Thai Beverage (SGX:Y92) comprise approximately half the weights of iEdge SG Advanced Manufacturing Index.
Emperador Inc. will join the STI effective the Monday 19 Sep, replacing ComfortDelGro following the recent semi-annual rebalance announcement. Emperador is a prominent high-growth international spirits company with a deep portfolio of globally recognised, market-leading whisky and brandy brands distributed in over 100 countries. Emperador is also a member of the Philippines Stock Exchange PSEi Index and debuted as an SGX secondary listing on 14 July.
The FTSE ST Small Cap Index constituents saw S$250 million in aggregate net institutional outflows in the 2022 year-to-date. The 16 constituents that attracted net institutional inflows were led by Riverstone, The Hour Glass and Chip Eng Seng, with the trio averaging 35% total returns in the 2022 year-to-date.
Global decelerating growth amid structurally-driven inflation, coupled with downside risks priced in to varying degrees each week, have provided a dynamic scope of stock market drivers in 2H22. With the uneven global growth outlooks extending to sectors & industries, the frequency of sector rotations may also intensify with the comparatively heavier slate of economic data points ahead.
Across the 40 largest Index weights of the iEdge SG Advanced Manufacturing Index, Aztech Global, UMS, Frencken, Venture Corp, ISDN, Valuetronics & AEM have ranked among the strongest 10 performers of the past 6 weeks, averaging 9% total returns. AEM reported that it is on track for a record FY, revising FY22 revenue guidance to S$750mi to S$800mil, with revenue for 1H22 increasing by 181% y-o-y.
The Bank, REIT and Industrial are sectors that saw the highest net institutional inflows on the 1st week of August, while other Financial Services, Telecommunications and Energy stocks saw the highest net institutional outflows. For the first 30 weeks of 2022 the STI has generated a 7.6% total return, compared to an 11.7% decline for the FTSE Developed Index.
This year the trio of DBS, UOB and OCBC have contributed more than 25% of the average daily turnover of the Singapore stock market, while averaging a 3% year-to-date total return following the 25% average total return in 2021. Institutions have also been net sellers of the trio in the 2022 year-to-date, following on from net buying in 2021.
These articles are provided by SGX My Gateway.
SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.